Neutrolis
Neutrolis is a candidate-stage company advancing its first-in-class therapies that target Neutrophil Extracellular Traps (NETs).
Neutrolis is a company in biotechnology, life science, medical based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2017.
Within the biotechnology, life science, medical space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Greater Boston Area, East Coast, New England, Northeastern US.
The company is listed at the Series_A stage of development.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $23.1M in funding.
| Sector | Biotechnology, Life Science, Medical |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $23,136,190 |
Website: www.neutrolis.com
Sign in to view the contact information we hold for Neutrolis.
Create a free account
Create a free account